MARKET EXPANSION OF HR+/HER2- BREAST CANCER THERAPEUTICS: A DEEP DIVE

Breast Cancer Survival Rates Breast cancer survival rates depend on several factors, including the stage at diagnosis, tumor subtype, and treatment options. The five-year survival rate for stage 2 breast cancer is approximately 90%, with slightly lower rates for stage 2B. Ongoing advancements in HR+ HER2- breast cancer treatment have significantly